ACM
MEDP icon

AlphaCrest Capital Management’s Medpace MEDP Stock Holding History

AlphaCrest Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,950
Closed -$621K – 690
2022
Q3 		$621K Buy
3,950
+156
+4% +$24.9K 0.04% 881
2022
Q2 		$568K Buy
3,794
+548
+17% +$79.3K 0.03% 911
2022
Q1 		$531K Sell
3,246
-947
-23% -$156K 0.03% 869
2021
Q4 		$913K Buy
4,193
+3,093
+281% +$648K 0.03% 840
2021
Q3 		$208K Sell
1,100
-2,200
-67% -$401K 0.01% 1208
2021
Q2 		$583K Buy
3,300
+1,900
+136% +$328K 0.03% 901
2021
Q1 		$230K Buy
+1,400
New +$214K 0.01% 1097
2019
Q4 		– Sell
-4,300
Closed -$361K – 1321
2019
Q3 		$361K Buy
+4,300
New +$325K 0.02% 1049

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AlphaCrest Capital Management's MEDP Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Medpace (MEDP) in Q4 2022, closing a stake of 3,950 shares — an estimated $621K sold.

AlphaCrest Capital Management first reported a position in MEDP in Q3 2019 and held it in 8 quarters. The position peaked at $913K in Q4 2021. 422 funds tracked by Wall St. Rank hold MEDP as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Medpace position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 3,950 Medpace shares in Q4 2022, an estimated $621K.
  • AlphaCrest Capital Management first reported a position in Medpace in Q3 2019 and held it in 8 quarters.
  • AlphaCrest Capital Management's Medpace position peaked at $913K in Q4 2021.
  • 422 funds tracked by Wall St. Rank held Medpace as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.